Lexicon Pharmaceuticals Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
104,126.00
100,294.00
4,682.00
141,429.00
129,050.00
120,548
Depreciation, Depletion & Amortization
2,863.00
1,928.00
727.00
2,056.00
3,399.00
3,683
Other Funds
26.00
-
70.00
-
-
13,032
Funds from Operations
96,061.00
77,914.00
12,885.00
132,081.00
126,137.00
103,833
Changes in Working Capital
4,982.00
2,292.00
171,891.00
43,547.00
59,257.00
44,774
Net Operating Cash Flow
91,079.00
75,622.00
184,776.00
175,628.00
185,394.00
148,607
Capital Expenditures
1,721.00
80.00
910.00
231.00
228.00
Sale of Fixed Assets & Businesses
130.00
2,170.00
335.00
-
-
Purchase/Sale of Investments
101,135.00
110,509.00
116,446.00
18,483.00
50,750.00
Net Investing Cash Flow
99,544.00
108,419.00
117,021.00
18,252.00
50,522.00
Issuance/Reduction of Debt, Net
1,574.00
82,425.00
1,859.00
2,016.00
143,625.00
Net Financing Cash Flow
1,389.00
283,808.00
2,032.00
987.00
149,933.00
Net Change in Cash
7,076.00
99,767.00
65,723.00
156,389.00
15,061.00
Free Cash Flow
92,800.00
75,702.00
183,866.00
175,859.00
185,622.00
Deferred Taxes & Investment Tax Credit
-
70.00
-
-
12,661.00
-
Change in Capital Stock
211.00
201,383.00
243.00
3,003.00
6,308.00
About Lexicon Pharmaceuticals
View Profile
